Clonal hematopoiesis identified as new risk factor for atherosclerosis

SAN DIEGO — An all-oral regimen for newly diagnosed acute promyelocytic leukemia (APL) proved “highly effective and safe,” with most patients avoiding chemotherapy altogether, a

Mod­er­na is beef­ing up its pipeline over the next five years with a plan launch up to 15 new prod­ucts and ad­vance up to 50

3D rendering of antibody drug conjugate molecules. Credit: Alpha Tauri 3D Graphics / Shutterstock.com. Biocytogen Pharmaceuticals (Beijing) and Myricx Bio have signed an antibody evaluation,